ARTICLE SUMMARY:
For the past 20 years or so, whenever medical device industry executives spoke of disruption, they almost always did so in terms of disruptive technologies. But over the past years, as cost pressures have mounted in healthcare, seeds of a new way to think about disruption in medtech have been planted. The debate has come to embrace the notion of business model disruption.
For the past 20 years or so, whenever medical device industry executives spoke of disruption, they almost always did so in terms of disruptive technologies and, most often, that disruption was considered a positive thing.
